Aclaris Therapeutics ACRS reported its Q2 earnings results on Wednesday, August 3, 2022 at 08:00 AM.
Here's what investors need to know about the announcement.
Aclaris Therapeutics beat estimated earnings by 13.89%, reporting an EPS of $-0.31 versus an estimate of $-0.36.
Revenue was down $296 thousand from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.09 which was followed by a 8.63% drop in the share price the next day.
Here's a look at Aclaris Therapeutics's past performance:
|Quarter||Q1 2022||Q4 2021||Q3 2021||Q2 2021|
To track all earnings releases for Aclaris Therapeutics visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.